Clovis Oncology Is A Biotechnology Company Based In Bouldercoloradofounded In 2009The Company Focuses On Precision Medicine By Developing Targeted Cancer Therapies And Diagnostic Tools That Help Identify Patients Who Are Most Likely To Benefit From Specific Treatmentsclovis Specializes In Acquiringdevelopingand Commercializing Anti Cancer Agentsparticularly For Cancer Subsets Defined By Genetic Mutations Or Biomarkers One Of Clovis S Key Products Is Rubracarucaparib A Parp Inhibitor Approved For Treating Ovarianfallopian Tubeand Primary Peritoneal Cancers In Patients With Brca Mutationsthe Company Collaborates With Diagnostic Firms To Create Companion Diagnosticsensuring That Therapies Are Effectively Matched To Patients Based On Their Molecular Profilesclovis Serves Healthcare Providers And Cancer Patientsparticularly Those With Biomarker Specific Cancersand Aims To Enhance Treatment Outcomes Through Its Strategic Approach Of Delivering The Right Drug To The Right Patient At The Right Time
